Implemed Anticipating Olimpicc 510(k) Clearance By Year-End
This article was originally published in The Gray Sheet
Implemed's 510(k) for the Olimpicc antimicrobial peripherally inserted central venous catheter should be cleared by the end of the year, the company says. Alongside data from an initial safety study, the submission, currently in development, will include results from two ongoing European trials that are evaluating the device's antimicrobial effectiveness.
You may also be interested in...
Experts think GLP-1s in neurodegeneration may be Novo Nordisk’s next opportunity and await readouts from the Phase II ELAD trial in Alzheimer's disease for signals.
France has announced a number of emergency measures to protect drug supplies threatened by the spread of the coronavirus.
Major generics companies have donated hydroxychloroquine sulfate doses for research and treatment of coronavirus. Companies are also donating hand sanitizer and personal protective equipment and are preparing to ramp up manufacturing and production.